55 related articles for article (PubMed ID: 28474103)
1. Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature.
Sahm F; Toprak UH; Hübschmann D; Kleinheinz K; Buchhalter I; Sill M; Stichel D; Schick M; Bewerunge-Hudler M; Schrimpf D; Zadeh G; Aldape K; Herold-Mende C; Beck K; Staszewski O; Prinz M; Harosh CB; Eils R; Sturm D; Jones DTW; Pfister SM; Paulus W; Ram Z; Schlesner M; Grossman R; von Deimling A
Acta Neuropathol; 2017 Jul; 134(1):155-158. PubMed ID: 28474103
[No Abstract] [Full Text] [Related]
2. NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.
Rutland JW; Gill CM; Loewenstern J; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Shrivastava RK; Fowkes M
Cancer Immunol Immunother; 2021 Jan; 70(1):169-176. PubMed ID: 32661686
[TBL] [Abstract][Full Text] [Related]
3. Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.
Bhattacharyya S; Oblinger JL; Beauchamp RL; Yin Z; Erdin S; Koundinya P; Ware AD; Ferrer M; Jordan JT; Plotkin SR; Xu L; Chang LS; Ramesh V
Neuro Oncol; 2023 Sep; 25(9):1617-1630. PubMed ID: 36806881
[TBL] [Abstract][Full Text] [Related]
4. A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in
Adams CL; Ercolano E; Ferluga S; Sofela A; Dave F; Negroni C; Kurian KM; Hilton DA; Hanemann CO
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070062
[TBL] [Abstract][Full Text] [Related]
5. Dental x-rays and risk of meningioma: response to Drs. Calnon, Jorgensen, and White.
Claus EB; Wiemels J; Wrensch M
Cancer; 2013 Jan; 119(2):465-6. PubMed ID: 23254687
[TBL] [Abstract][Full Text] [Related]
6. Aggressive human MenG C meningiomas have a molecular counterpart in canines.
Harmanci AS; Boudreau B; Lau S; Hosseingholi Nouri S; Mandel JJ; Lu HC; Harmanci AO; Klisch TJ; Levine JM; Patel AJ
Acta Neuropathol; 2024 Feb; 147(1):42. PubMed ID: 38376654
[No Abstract] [Full Text] [Related]
7. Intratumor and informatic heterogeneity influence meningioma molecular classification.
Vasudevan HN; Choudhury A; Hilz S; Villanueva-Meyer JE; Chen WC; Lucas CG; Braunstein SE; Oberheim Bush NA; Butowski N; Pekmezci M; McDermott MW; Perry A; Solomon DA; Magill ST; Raleigh DR
Acta Neuropathol; 2022 Sep; 144(3):579-583. PubMed ID: 35759011
[No Abstract] [Full Text] [Related]
8. Meningioma risk stratification with a targeted gene-expression biomarker.
Nat Med; 2023 Dec; 29(12):3020-3021. PubMed ID: 38057502
[No Abstract] [Full Text] [Related]
9. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
Mack SC; Pajtler KW; Chavez L; Okonechnikov K; Bertrand KC; Wang X; Erkek S; Federation A; Song A; Lee C; Wang X; McDonald L; Morrow JJ; Saiakhova A; Sin-Chan P; Wu Q; Michaelraj KA; Miller TE; Hubert CG; Ryzhova M; Garzia L; Donovan L; Dombrowski S; Factor DC; Luu B; Valentim CLL; Gimple RC; Morton A; Kim L; Prager BC; Lee JJY; Wu X; Zuccaro J; Thompson Y; Holgado BL; Reimand J; Ke SQ; Tropper A; Lai S; Vijayarajah S; Doan S; Mahadev V; Miñan AF; Gröbner SN; Lienhard M; Zapatka M; Huang Z; Aldape KD; Carcaboso AM; Houghton PJ; Keir ST; Milde T; Witt H; Li Y; Li CJ; Bian XW; Jones DTW; Scott I; Singh SK; Huang A; Dirks PB; Bouffet E; Bradner JE; Ramaswamy V; Jabado N; Rutka JT; Northcott PA; Lupien M; Lichter P; Korshunov A; Scacheri PC; Pfister SM; Kool M; Taylor MD; Rich JN
Nature; 2018 Jan; 553(7686):101-105. PubMed ID: 29258295
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas.
Agnihotri S; Suppiah S; Tonge PD; Jalali S; Danesh A; Bruce JP; Mamatjan Y; Klironomos G; Gonen L; Au K; Mansouri S; Karimi S; Sahm F; von Deimling A; Taylor MD; Laperriere NJ; Pugh TJ; Aldape KD; Zadeh G
Nat Commun; 2017 Aug; 8(1):186. PubMed ID: 28775249
[TBL] [Abstract][Full Text] [Related]
11. The whole-genome landscape of medulloblastoma subtypes.
Northcott PA; Buchhalter I; Morrissy AS; Hovestadt V; Weischenfeldt J; Ehrenberger T; Gröbner S; Segura-Wang M; Zichner T; Rudneva VA; Warnatz HJ; Sidiropoulos N; Phillips AH; Schumacher S; Kleinheinz K; Waszak SM; Erkek S; Jones DTW; Worst BC; Kool M; Zapatka M; Jäger N; Chavez L; Hutter B; Bieg M; Paramasivam N; Heinold M; Gu Z; Ishaque N; Jäger-Schmidt C; Imbusch CD; Jugold A; Hübschmann D; Risch T; Amstislavskiy V; Gonzalez FGR; Weber UD; Wolf S; Robinson GW; Zhou X; Wu G; Finkelstein D; Liu Y; Cavalli FMG; Luu B; Ramaswamy V; Wu X; Koster J; Ryzhova M; Cho YJ; Pomeroy SL; Herold-Mende C; Schuhmann M; Ebinger M; Liau LM; Mora J; McLendon RE; Jabado N; Kumabe T; Chuah E; Ma Y; Moore RA; Mungall AJ; Mungall KL; Thiessen N; Tse K; Wong T; Jones SJM; Witt O; Milde T; Von Deimling A; Capper D; Korshunov A; Yaspo ML; Kriwacki R; Gajjar A; Zhang J; Beroukhim R; Fraenkel E; Korbel JO; Brors B; Schlesner M; Eils R; Marra MA; Pfister SM; Taylor MD; Lichter P
Nature; 2017 Jul; 547(7663):311-317. PubMed ID: 28726821
[TBL] [Abstract][Full Text] [Related]
12. Gene transcript fusions are associated with clinical outcomes and molecular groups of meningiomas.
Zakimi N; Nguyen MP; Raleigh DR
Acta Neuropathol; 2024 Mar; 147(1):57. PubMed ID: 38509407
[No Abstract] [Full Text] [Related]
13. Molecular classification and grading of meningioma.
Nasrallah MP; Aldape KD
J Neurooncol; 2023 Jan; 161(2):373-381. PubMed ID: 36802047
[TBL] [Abstract][Full Text] [Related]
14. The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J; Ishaque N; Koll R; Gu Z; Schumann E; Sieverling L; Uhrig S; Hübschmann D; Toprak UH; López C; Hostench XP; Borgoni S; Juraeva D; Pritsch F; Paramasivam N; Balasubramanian GP; Schlesner M; Sahay S; Weniger M; Pehl D; Radbruch H; Osterloh A; Korfel A; Misch M; Onken J; Faust K; Vajkoczy P; Moskopp D; Wang Y; Jödicke A; Trümper L; Anagnostopoulos I; Lenze D; Küppers R; Hummel M; Schmitt CA; Wiestler OD; Wolf S; Unterberg A; Eils R; Herold-Mende C; Brors B; ; Siebert R; Wiemann S; Heppner FL
Nat Commun; 2022 May; 13(1):2558. PubMed ID: 35538064
[TBL] [Abstract][Full Text] [Related]
15. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
Choudhury A; Magill ST; Eaton CD; Prager BC; Chen WC; Cady MA; Seo K; Lucas CG; Casey-Clyde TJ; Vasudevan HN; Liu SJ; Villanueva-Meyer JE; Lam TC; Pu JK; Li LF; Leung GK; Swaney DL; Zhang MY; Chan JW; Qiu Z; Martin MV; Susko MS; Braunstein SE; Bush NAO; Schulte JD; Butowski N; Sneed PK; Berger MS; Krogan NJ; Perry A; Phillips JJ; Solomon DA; Costello JF; McDermott MW; Rich JN; Raleigh DR
Nat Genet; 2022 May; 54(5):649-659. PubMed ID: 35534562
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas.
Kirches E; Sahm F; Korshunov A; Bluecher C; Waldt N; Kropf S; Schrimpf D; Sievers P; Stichel D; Schüller U; Schittenhelm J; Riemenschneider MJ; Karajannis MA; Perry A; Pietsch T; Boekhoff S; Capper D; Beck K; Paramasivam N; Schlesner M; Brastianos PK; Müller HL; Pfister SM; Mawrin C
Acta Neuropathol; 2021 Nov; 142(5):873-886. PubMed ID: 34495383
[TBL] [Abstract][Full Text] [Related]
17. Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone.
Lutsik P; Baude A; Mancarella D; Öz S; Kühn A; Toth R; Hey J; Toprak UH; Lim J; Nguyen VH; Jiang C; Mayakonda A; Hartmann M; Rosemann F; Breuer K; Vonficht D; Grünschläger F; Lee S; Schuhmacher MK; Kusevic D; Jauch A; Weichenhan D; Zustin J; Schlesner M; Haas S; Park JH; Park YJ; Oppermann U; Jeltsch A; Haller F; Fellenberg J; Lindroth AM; Plass C
Nat Commun; 2020 Oct; 11(1):5414. PubMed ID: 33110075
[TBL] [Abstract][Full Text] [Related]
18. Pediatric meningioma: a clinicopathologic and molecular study with potential grading implications.
Toland A; McNulty SN; Pekmezci M; Evenson M; Huntoon K; Pierson CR; Boue DR; Perry A; Dahiya S
Brain Pathol; 2020 Nov; 30(6):1134-1143. PubMed ID: 32716568
[TBL] [Abstract][Full Text] [Related]
19. Highlights of the inaugural ten - the launch of Neuro-Oncology Advances.
Nassiri F; Aldape K; Alhuwalia M; Brastianos P; Ducray F; Galldiks N; Kim A; Lamszus K; Mitchell D; Nabors LB; Nam DH; Natsume A; Ng HK; Niclou S; Sahm F; Short S; Walsh K; Wick W; Zadeh G
Neurooncol Adv; 2019; 1(1):vdz016. PubMed ID: 32642652
[No Abstract] [Full Text] [Related]
20. The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.
Horbinski C; Ligon KL; Brastianos P; Huse JT; Venere M; Chang S; Buckner J; Cloughesy T; Jenkins RB; Giannini C; Stupp R; Nabors LB; Wen PY; Aldape KJ; Lukas RV; Galanis E; Eberhart CG; Brat DJ; Sarkaria JN
Neuro Oncol; 2019 Dec; 21(12):1498-1508. PubMed ID: 31276167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
